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doi:10.1016/j.ejvs.2010.03.018Abstract Objectives: To analyse early and midterm results of thoracic aortic endografting
(TEVAR) in the aortic arch.
Methods: Between January 1997 and February 2009 178 patients received TEVAR in the aortic
arch at our institution. This population was subdivided into four groups according to the prox-
imal landing zone (LZ) classification in the aortic arch by Ishimaru et al. and a retrospective
analysis regarding perioperative mortality, morbidity and endoleak formation was performed.
Results: The overall 30-day mortality rate was 14% with no statistical significant difference
between LZ’s 0e3 (pZ0.274). Renal insufficiency (hazard ratio (HR) 2.5; pZ0.0119), age
>75 years (HR 3.1; pZ0.0019) and emergency procedures (HR 8.9; p < 0.0001) were indepen-
dent predictors of death. There was no significant difference regarding type I (pZ0.07) or type
III (pZ0.49) endoleaks between the proximal LZs, but a significant difference regarding the
development of type II endoleaks (pZ0.01).
Conclusions: The present study showed no influence of the proximal LZ on perioperative
mortality and morbidity rate. Furthermore it did not influence relevant (type I/III) endoleak
formation.
ª 2010 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Vascular pathologies involving the aortic arch are consid-
ered to be a special challenge for vascular and cardiovas-
cular surgeons. Conventional open aortic arch replacement
using extracorporal circulation, selective antegrade cere-
bral perfusion and moderate hypothermia is associated6221 566249; fax: þ49 6221
ch@med.uni-heidelberg.de
ty for Vascular Surgery. Publishewith a relevant morbidity and mortality rate.1,2 As
a consequence thoracic endovascular aortic repair (TEVAR)
as a potentially less invasive treatment alternative seems
especially appealing in high-risk patients. While the
development of fenestrated endografts is still ongoing,
frequently hybrid procedures, combining supra-aortic
vessel debranching to achieve sufficient landing zone and
TEVAR are necessary.3e6 These re-routing procedures have
an increasing invasiveness and perioperative morbidity and
mortality from subclavian transposition or bypass grafting
to hemiarch or complete debranching.7d by Elsevier Ltd. All rights reserved.
694 P. Geisbu¨sch et al.The aim of this study was therefore to analyse short and
midterm results of TEVAR in the aortic arch regarding per-
ioperative mortality and morbidity as well as midterm
survival, stratified by the required proximal landing zone.Methods
Patient population
Between January 1997 and February 2009 a total of 236
consecutive patients received TEVAR in our institution; the
aortic arch was involved in 178 patients (126 men, median
age 72 years, range: 64e79). This patient population was
subdivided into four groups according to the proximal
landing zone (LZ) classification in the aortic arch by Ishi-
maru et al. (Zone 0e3).8
Indications for treatment in all four groups are given in
Table 1 and show the complete spectrum of aortic pathol-
ogies with the greatest proportion of emergency operations
in zones 2 and 3. This is caused by the high amount of acute
aortic dissections (nZ23) and traumatic transections
(nZ14), which are typically localised in this aortic section
(zone 3) and the referral pattern of our university hospital.
Baseline characteristics and cardiovascular risk factors
for patients in group 0e3 are given in Table 2 and reveal
a statistical significant difference regarding history of
smoking, renal insufficiency and diabetes mellitus between
the groups. For risk stratification the logistic EuroScore and
ASA classification were used, which showed no statistical
difference between the patients of zone 0e3.9,10 The
EuroScore is a commonly used pre-operative risk stratifi-
cation system for cardiac and open thoracic aortic surgery
that includes demographic, cardiac-related and surgery-
related variables.9,10
Pre-interventional imaging
All patients received pre-operative computed tomography
(CTA) or magnetic resonance angiography (MRA). Volu-
metric imaging (isotropic voxel with thin slice thickness,
ideally 2 mm), image post-processing in three dimension
(3D) using multi-planar reformation (MPR) and centreline
measurements were used for procedure- and stent-graftTable 1 Indications for TEVAR in all patients with aortic arch p
Indications Zone 0 (n Z 10) Zone 1
TAA 6 8
TAAA 2 3
TAT e 1
AAD e 4
CEAD e 6
PAU/IMH 2 5
ABF e 1
Emergency procedures 3 (30) 11 (44)
Values are presented as n (%).
Abbreviations: TAA: thoracic aortic aneurysm, TAAA: thoraco-abdomin
aortic dissection, CEAD: chronic expanding aortic dissection, PAU: p
bronchial fistula.selection as well as pre-operative planning of the implan-
tation strategy whenever possible. Aortic diameters and
length, and thus stent-graft selection was calculated using
centreline measurements.11 A sufficient LZ was defined as
a thrombus-free, non-calcified, >2-cm-long segment of the
arch with a maximum diameter 15e20% of the largest
available stent-graft diameter.
Procedure
All surgical procedures were performed in an operation
theatre equipped with fluoroscopic and angiographic
capabilities (Series 9800; OEC Medical Systems, Inc., Salt
Lake City, UT, USA until April 2007, after that Axiom U,
Siemens, Forchheim, Germany) and a carbon fibre oper-
ating table. Our procedure protocol has been published
before.12
All cases of LZ 0 were performed under general anaes-
thesia. In LZ 1e3 epidural or spinal anaesthesia could be
applied in 5 cases (3%), local anaesthesia was used in 11
patients (6%) and 91% of all patients received general
anaesthesia.
For exact stent-graft positioning in the aortic arch we
aimed for an adenosine-induced cardiac arrest (AICA) for all
patients with LZ 0e1. This technique could be applied in all
elective cases except a few emergency ones.
Routine vascular access was obtained by transfemoral
incision in 130 patients (73%). In 35 cases (20%) with small
femoral vessel diameters a Dacron conduit prosthesis to the
right iliac common artery was used.
Hybrid procedures
Hybrid procedures with supra-aortic debranching were
performed in 32 cases. All LZ 0 cases received revascular-
isation of the supra-aortic branches via bypass grafting
from the ascending aorta. In all LZ 1 patients, extra-
anatomic revascularisation of the left common carotid
artery with carotidecarotid crossover bypass or trans-
position was performed. An additional 14 patients received
primary revascularisation of the left subclavian artery (LSA)
in this group.
Revascularisation of the LSAwas performed in six patients
before TEVAR in LZ 2 (coverage of the LSA). Selection criteriaathologies (n Z 178).
(n Z 25) Zone 2 (n Z 55) Zone 3 (n Z 88)
13 33
6 16
6 8
9 14
11 9
10 15
3 2
35 (64) 47 (54)
al aortic aneurysm, TAT: traumatic aortic transection, AAD: acute
enetrating aortic ulcer, IMH: intramural hematoma, ABF: aorto-
Table 2 Pre-operative characteristics of all patients stratified for different proximal landing zones (classification by
Ishimaru et al.)8.
Zone 0 (n Z 10) Zone 1 (n Z 25) Zone 2 (n Z 55) Zone 3 (n Z 88) P value
Age 64.8 (61e84) 63.8 (32e84) 63.2 (28e84) 66.7 (2e89) 0.136
Gender (male) 8 (80) 17 (68) 38 (69) 62 (70) 0.932
ASA III þ IV 10 (100) 22 (88) 41 (75) 75 (85) 0.186
logEuroscore 20.9 (12e80) 27.3 (3e73) 18.1 (3e65) 21.3 (3e94) 0.489
Hypertension 10 (100) 23 (92) 42 (78) 77 (88) 0.186
History of smoking 8 (80) 10 (40) 21 (38) 55 (63) 0.005
CHD 6 (60) 10 (40) 14 (26) 33 (38) 0.162
Renal insufficiency 2 (20) 5 (20) 7 (13) 31 (35) 0.019
COPD 3 (30) 4 (16) 6 (11) 23 (26) 0.117
Diabetes 4 (40) 4 (16) 2 (4) 10 (11) 0.010
Previous aortic surgery 2 (20) 5 (20) 9 (16) 24 (27) 0.492
Values are presented as n (%) or median (range).
Abbreviations: CHD: coronary heart disease, COPD: chronic obstructive pulmonary disease, ASA: American Society of Anaesthesiologists
classification.
TEVAR in the Aortic Arch 695for revascularisation included patients with an increased risk
for paraplegia (previous aortic surgery, long covered aortic
segment, etc.), previous aorto-coronary bypass grafting
using the internal mammary artery or an insufficient
contralateral vertebral artery. A total of 17 patients required
additional thoraco-abdominal hybrid procedures (LZ 0: two
patients, LZ 1: two patients, LZ 2: three patients and LZ 3: 10
patients). Our early experience with hybrid procedures in
TAAA has been published recently.3,13
Stent-grafts
A total of 293 endografts were implanted, with 108 patients
receiving a single stent-graft. Four types of stent-grafts were
implanted: Talent and Valiant (Medtronic Vascular, Santa
Rosa, CA, USA), TAG (W.L. Gore & Associates, Flagstaff, AZ,
USA) and Zenith (Cook Inc., Bloomington, Indiana, USA).
For stent-graft diameter selection 15e20% oversizing in
aneurysms and 10% in aortic dissections or transections
were applied.
Follow-up
The follow-up protocol included post-operative CTA before
discharge, clinical examination, plain chest radiography
and CTA/MRA 6 and 12 months post-operatively and annu-
ally thereafter. Additionally, all patients with hybrid
procedures received duplex scanning to exclude bypass
stenosis or occlusion. A total of 11 patients were lost in
follow-up (seven patients refused serial aortic imaging and
four patients could not be located). Mean follow-up was
33.2 months (range 0.1e141.5 months).
Definitions and statistical analysis
The definitions of technical and clinical success are
according to the reporting standards for endovascular
aortic aneurysm repair.13 Endoleaks were catagorised as
previously described by White et al.14 and specified as
primary endoleaks if apparent on intra-operative controlangiography or primary post-operative CTA control.
Secondary endoleaks were defined as occurring during
follow-up.
A retrospective analysis of the prospectively collected
data was performed. Continuous data are described by
mean SD or median (range). Survival rates were estimated
by KaplaneMeier. The log-rank test was used for comparison
of survival distributions between subgroups defined by LZ.
For categorial data comparison of subgroups was carried out
by Fisher’s exact test and in case of continuous or ordinal
data ManneWhitney U-test was used. Cox proportional
hazard model (Cox regression analysis) and logistic regres-
sion analysis were used to identify independent risk factors
affecting survival and endoleak formation. All statistical
analysis was performed using SAS for Windows, (Version 9.2,
SAS Institute Inc., Cary, NC, USA) andMedCalc (Version 9.5.2,
MedCalc software, Mariakerke, Belgium). A p value <0.05
was defined as statistically significant.Results
Mortality and morbidity
Operative results are presented in Table 3. Overall 30-day
mortality was 14%, with the highest perioperative mortality
in LZ 2 and 3 (pZ0.274). Cox proportional hazard regression
showed renal insufficiency (HR 2.5; 95% confidence interval
(CI) 1.2e4.9), age >75 years (HR 3.1; 95% CI 1.5e6.2) and
the necessity for an emergency procedure (HR 8.9; 95% CI
3.1e25.2) as independent predictors of death. (Table 4).
The overall post-operative morbidity rate was 53% with
no significant difference between LZ 0e3 (pZ0.370),
although the greatest proportion of cardiac, respiratory and
renal complications were seen in patients with LZ 0.
Neurological complications (stroke and paraplegia)
occurred in 6.1% (11/178) patients. The perioperative
stroke rate was 3.3%, with a maximum in LZ 1 (8%) and
a minimum in LZ 0 (0%). Paraplegia was seen in five patients
(2.8%). This includes three patients with simultaneous
thoraco-abdominal aortic hybrid procedures, one patient
Table 3 Operative results, specified for different proximal landing zones.
Zone 0 (n Z 10) Zone 1 (n Z 25) Zone 2 (n Z 55) Zone 3 (N Z 88) P value
30-day mortality 1 (10) 1 (4) 11 (20) 12 (13.6) 0.274
Perioperative morbidity 8 (80) 13 (52) 29 (53) 44 (50) 0.370
Stroke 0 (0) 2 (8) 1 (1.8) 3 (3)
Paraplegia 0 (0) 1 (4) 1 (1.8) 3 (3)
Cardiac complications 5 (50) 2 (8) 7 (13) 12 (14)
Respiratory failure 4 (40) 4 (16) 15 (27) 18 (20)
Renal failure 4 (40) 1 (4) 6 (11) 13 (15)
Wound infection 1 (10) 3 (12) 2 (4) 8 (9)
Open conversion
- Early 0 (0) 0 (0) 0 (0) 1 (1)
- Late 0 (0) 0 (0) 3 (5) 3 (3)
ICU stay in d
- Revascularisation 3 (1e60) 2 (1e12) 3 (0e5) n.a.
- TEVAR 3 (1e60) 2 (0e12) 2 (1e40) 2 (0e47)
Endoleak: primary þ secondary
Type I 3 (33) 6 (24) 6 (11) 8 (9) 0.073
Type II 3 (33) 2 (8) 9 (16) 4 (5) 0.015
Type III 0 (0) 0 (0) 0 (0) 3 (3) 0.499
Re-intervention 5 (50) 9 (36) 10 (18) 17 (19)
Values are presented as n (%) or median (range).
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ment and TEVAR for a contained ruptured TAAA thor-
acoabdominal aortic aneurysm and one patient with an
acute aortic dissection Type B.
Technical success
The technical success rate was 89% with 19 patients showing
a primary type I or III endoleak and one patient requiring
early conversion (n Z 20/178; 11%). The technical success
rate was 80% in LZ 0 (two patients endoleak type I), 76% in LZ
1 (six patients endoleak type I), 95% in LZ 2 (three patients
endoleak type I) and 90% in LZ 3 (seven patients endoleak,
type I þ 1 patient endoleak type III þ 1 early conversion). All
patients are described in detail in the following.
Endoleaks and re-intervention
Primary endoleaks were detected in 36 patients (20%), with
an increasing incidence towards the proximal aortic arch
(from LZ 3 (14%) to LZ 0 (40%)), although this just did not
reach statistical significance (pZ0.05). Endoleaks type II
from the left subclavian artery were seen in 10 patients. This
included one patient in LZ 0, 2 patients in LZ 1 and seven inTable 4 Risk factor analysis regarding perioperative
death (Cox regression analysis).
Variable Hazard
ratio
95% CI P value
Emergency procedure 8.9 3.1e25.2 <0.0001
Renal insufficiency 2.5 1.2e4.9 0.0119
Age > 75 years 3.1 1.5e6.2 0.0019LZ 2. These endoleaks sealed spontaneously in seven
patients during follow-up, while three patients required
surgical intervention. Early conversion (0.6%) was necessary
in a 65-year-old patient with a TAA in the beginning of the
TEVAR era (1998) due to a stent-graft collapse that could not
be resolved intra-operatively by endovascular means.
Secondary endoleaks occurred in seven patients (4%)
that included two patients with a type III endoleak. One
patient underwent successful endorepair, the second one
required late conversion due to an aorto-oesophageal
fistula caused by the fractured stent wire.14
The total rateofendoleak formation (primaryþ secondary)
was independently predictedbyamoreproximal LZ (OR0.612,
95% CI 0.421e0.8884) and an increasing number of endopros-
thesis used in one procedure (OR 1.438, 95% CI 1.011e2.045)
(Table 5).
The overall re-intervention rate was 23% with an
increasing proportion of re-interventions towards the more
proximal LZs (Table 3).Midterm survival analysis
A total of 21 patients died during follow-up, 14 due to aortic
or procedure unrelated causes. The causes of death in
these patients were myocardial infarction in six patients,
pneumonia in three patients, lung cancer in two patients
and stroke/intracerebral bleeding in two patients. One
patient died of a sepsis caused by an osteomyelitis after
repeated spine surgery.
Aortic-related death during follow-up occurred in seven
patients (4%). This included two patients with an aortic
rupture caused by a primary type I endoleak. Both patients
refused further re-intervention and/or were incompliant
regarding post-operative follow-up. Two patients died of
Table 5 Risk factor analysis regarding primary and
secondary endoleak formation.
Variable Odds
Ratio
95% CI P value
Number of stent-graft used 1.438 1.011e2.045 0.0427
Proximal landing zone 0.612 0.421e0.888 0.0098
TEVAR in the Aortic Arch 697a recurrent bleeding from a pre-existing aorto-oesophageal
fistula. Infrarenal aortic rupture caused by a chronic
expanding aortic dissection (CEAD) type Stanford B
occurred in one patient, who had also refused elective re-
intervention. One patient died of multi-organ failure during
re-intervention (thoraco-abdominal hybrid procedure per-
formed for CEAD). One 81-year-old patient died of an
ascending aortic rupture 2.5 years post-operatively after
a successful aortic arch hybrid procedure for a TAA. Open
cardiac surgery with replacement of the ascending aorta
was denied in this highly co-morbid patient.
Discussion
The present study shows that endografting in the aortic
arch is associated with a relevant mortality (14%) and
morbidity rate (53%). No statistically significant difference
regarding the proximal LZs could be shown, but these
results are prone to serious limitations (see section titled
‘Limitations’). This result is in line with other series that
also demonstrated no influence of the proximal LZ or the
debranching procedure on perioperative mortality.15,16
Nevertheless, it is obvious that complete debranching
procedures represent a different procedure category
(compared to partial re-routing) with an increased
mortality and morbidity rate that could possibly not be
shown in this series due to the relatively small number of
patients in this cohort. Mortality rates after TEVAR in the
aortic arch vary from 0% to 8% and are thus below our
reported mortality of 14%.15e17 This might be explained as
a result of the large proportion (54%) of emergency proce-
dures performed in our patient cohort, which are associ-
ated with an increased perioperative mortality (HR: 8.8;
p < 0.0001) as shown in our study. Besides the necessity for
emergency procedures, age >75 years (HR 3.1; pZ0.0019)
and renal insufficiency (HR 2.5; pZ0.0119) could be iden-
tified as independent risk factors influencing perioperative
survival. The strong influence of renal insufficiency could
be explained by the inclusion of patients with acute,
complicated aortic dissections in LZ 2/3 and thus reflect
the poor outcome in this subgroup. This is supported by the
fact, that patients with LZ 2/3 showed the highest 30-day
mortality in this cohort. Additionally, Gottardi et al. could
demonstrate in their series of 73 patients with aortic arch
hybrid procedure that survival was predicted by higher
logistic EuroSCORE levels (OR 1.8; pZ0.020), also reflecting
increased patient co-morbidities and emergency situa-
tions.15 Furthermore, we are not aware of any other series
focussing on risk factor analysis in the aortic arch.
The present series demonstrates that endoleak formation
was associated with a more proximal LZ (OR 0.612;
pZ0.0098). However, the sub-analysis showed that thisresult is not caused by relevant (type I/III) endoleaks but
influenced by a significantly increased amount of type II
endoleaks. This is in line with Melissano et al. who showed no
significant difference regarding primary or secondary endo-
leak formation for the different aortic arch segments.16
Additionally Gottardi et al. recently proved that the type of
arch re-routing (and thus the LZ) was not associated with an
increased risk of early or late endoleak formation.15
In their series, early and late endoleak formation was
predicted by an increasing number of endoprostheses used
per procedure, which was proved in our series (OR 1.438;
pZ0.0427) as well. A possible explanation for this could be
an increase of type III endoleaks, which we have not seen in
our series. The amount of endoprostheses used might
therefore reflect more complex TEVAR procedures
including thoraco-abdominal stent-graft placement with an
increasing risk of type II endoleaks.
Patients with a proximal LZ 3 showed the lowest rate of
endoleaks in our series, which has clearly influenced the
overall results. The inclusion of these patients is certainly
debatable as many authors would consider LZ 3 as ‘pure’
descending aorta. In our concern, the proximal LZ 3 is
located just distal of the left subclavian artery in the
transition of the distal arch to the descending aorta.
Depending of the location of the left subclavian artery
(e.g., in patients with a bovine arch) the LZ 3 might
therefore even end up in the mid-arch section in some
cases. Additionally, we think that this section of the aorta
is still exposed to the heavy pulsatile movements of the
aortic arch, reflected by the high amount of pathologies
(e.g., dissections) in this aortic segment. Stent-graft
procedures in the aortic arch with or without concomi-
tant debranching represent technical challenging proce-
dures. Frequently, the stent-graft does not adapt to the
inner curve of the aortic arch but tends towards the outer
curve, leaving a triangular space between the endograft
and the inner curve (bird peak sign) at risk for endoleak
formation, endograft compression or collapse. This is
especially prevalent in the mid-aortic section (LZ 1 and 2)
and should be considered while planning these proce-
dures. Future device development should therefore
include longer, flexible devices, especially designed for
the aortic arch, as this might substantially reduce endo-
leak formation. Published technical success rates from
other groups vary between 66% and 100% and are thus in
line with our results.16,18e20
Our results showed a sustained treatment success
regarding midterm survival with 75% and 67% survival rates
after 1 and 3 years, which is also in line with the literature.6
Nevertheless, we experienced aortic-related death and
secondary endoleak formation in a relevant (4%) proportion
of patients, which underscores the outstanding relevance
and necessity for continued follow-up, including dedicated
serial aortic imaging and image post-processing.21
Current surgical treatment alternatives for aortic arch
pathologies include open conventional arch replacement
with/without (frozen) elephant trunk technique.22e26
A comparison of these techniques with endovascular
procedures, especially aortic arch hybrid procedures seems
difficult due to selection bias, as the patient populations
frequently show decisive differences regarding age or co-
morbidities. Recently, techniques that allow a total
698 P. Geisbu¨sch et al.endovascular repair of arch pathologies using branched
endografts are developing and show encouraging initial
results.27e29 Although these techniques might represent the
future of aortic arch repair, a broader application, partic-
ularly in emergency situations (w50% of all arch patholo-
gies) is still limited by the availability of these custom-
made endoprostheses today.
Limitations
The major limitation of these results concern the hetero-
geneity of the study population in regard to (a) the aortic
pathologies (b) the different proportion of emergency
procedures in the subgroups and (c) the revascularisation
procedures used. Additionally our study covers a large time
period (12 years) with significant improvements in stent-
graft technology, operative and perioperative manage-
ment. These influences could mean that a true comparison
between mortality and morbidity for different LZs can not
be made.
Conclusions
The present study could show no influence of the proximal
LZ on perioperative mortality and morbidity rate, but
serious study limitations have to be taken into account
while drawing this conclusion. Age, renal insufficiency and
emergency procedures were independent predictors of
death. The proximal LZ did not influence relevant (type I/
III) endoleak formation.
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